From Full Outsourcing to CRO-Agnostic Oversight: How UCB Is Rethinking Operating Models Under R3
At the Veeva Clinical Oversight Forum in Copenhagen, we spoke with David Appel, CSM Team Lead at UCB, and...
What R3 Really Means for Outsourcing Decisions at Novo Nordisk
At the Veeva Clinical Oversight Forum in Copenhagen, we spoke with Ibrahim Kamstrup-Akkaoui, VP of Business Architecture and Partnerships...
Transforming Oversight Under R3: A Conversation with Pinar Bénet
At the Veeva Clinical Oversight Forum, we spoke with Pinar Bénet, Senior Director of GTM Strategy and Clinical Lead...
Building a Scalable Clinical Foundation at Intercept Pharmaceuticals
At the Veeva R&D Summit, we spoke with Bill Wallace, CIO of Intercept Pharmaceuticals, about the company’s work to...
AI-enabled eConsent: Balancing Personalization with Human Oversight
In this interview, Vinita Navadgi, Sr. Director, Digital Patient Suite, IQVIA, shares a practical, thought-leading view on AI-driven electronic...
Rethinking EDC: Why AI Demands a New Foundation for Clinical Data Management
At Veeva R&D and Quality Summit 2025, we spoke with Manny Vazquez, Senior Director of Clinical Data Strategy at...
Redefining Clinical Imaging: How a Site-First Approach is Setting a New Standard for Transparency and Data Integrity
At DPHARM, we spoke with Patrick McNamara, Chief Commercial Officer at Yunu, about how the company is transforming imaging...
Building Trust Through Transparency: Apellis Pharma’s Steph Viscomi on Lean TMF and Site Collaboration
At the Veeva R&D and Quality Summit, we spoke with Steph Viscomi, Head of TMF at Apellis Pharma, about...
ProofPilot and Lokavant Aquisition: Aligning Trial Ops with Predictive Analytics
In this interview, we sit down with Chris Venezia, CEO, and Joseph Kim, Chief Strategy Officer at ProofPilot, to...
Using Behavioral AI to Predict and Prevent Clinical Trial Dropouts
At SCOPE Europe 2025, we spoke with Dominique Demolle, CEO of Cognivia, about how behavioral AI is helping sponsors...